When we think of kidney transplantation, we usually focus on surgery, immunosuppressive drugs, and early post-operative tests ...

Objectives Delays in cancer diagnosis for patients with non-specific symptoms (NSSs) lead to poorer outcomes. Rapid ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression ...

Tech and cancer researchers are publicly releasing an AI tool that can perform sophisticated tumor analysis in a fraction of the time and cost of existing methods.

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

According to Mordor Intelligence, the global exosomes market is valued at USD 0.71 billion in 2025 and is projected to surpass USD 2.21 ...

This valuable study presents an analysis of the gene regulatory networks that contribute to tumour heterogeneity and tumor plasticity in Ewing sarcoma, with key implications for other fusion-driven ...

Antibody Specificity Testing Market is expected to Reach to US $1.9 Bn by 2035, Driven by Rising Demand for Personalized ...

According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...

Raman technology provides real-time insights into polymer behavior, enabling advanced research and faster quality control ...

A small nutrition study suggests that orange-juice consumption might influence gene activity in immune cells.

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo Fisher Scientific’s Ravi Gupta and Dr. Robert Balog.